Hong Kong · Delayed Price · Currency is HKD AIM Vaccine Statistics
Total Valuation
AIM Vaccine has a market cap or net worth of HKD 3.53 billion. The enterprise value is 5.29 billion.
| Market Cap | 3.53B |
| Enterprise Value | 5.29B |
Important Dates
The last earnings date was Monday, March 30, 2026.
| Earnings Date | Mar 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AIM Vaccine has 1.23 billion shares outstanding. The number of shares has increased by 1.06% in one year.
| Current Share Class | 507.67M |
| Shares Outstanding | 1.23B |
| Shares Change (YoY) | +1.06% |
| Shares Change (QoQ) | +0.45% |
| Owned by Insiders (%) | 27.84% |
| Owned by Institutions (%) | 4.07% |
| Float | 328.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.72 |
| PB Ratio | 1.08 |
| P/TBV Ratio | 2.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.04 |
| EV / Sales | 4.08 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.66, with a Debt / Equity ratio of 0.60.
| Current Ratio | 0.66 |
| Quick Ratio | 0.50 |
| Debt / Equity | 0.60 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.59 |
Financial Efficiency
Return on equity (ROE) is -22.72% and return on invested capital (ROIC) is -4.79%.
| Return on Equity (ROE) | -22.72% |
| Return on Assets (ROA) | -1.87% |
| Return on Invested Capital (ROIC) | -4.79% |
| Return on Capital Employed (ROCE) | -6.02% |
| Weighted Average Cost of Capital (WACC) | 4.36% |
| Revenue Per Employee | 884,838 |
| Profits Per Employee | -512,728 |
| Employee Count | 1,466 |
| Asset Turnover | 0.17 |
| Inventory Turnover | 1.00 |
Taxes
| Income Tax | -25.40M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.82% in the last 52 weeks. The beta is 0.20, so AIM Vaccine's price volatility has been lower than the market average.
| Beta (5Y) | 0.20 |
| 52-Week Price Change | -16.82% |
| 50-Day Moving Average | 3.05 |
| 200-Day Moving Average | 3.81 |
| Relative Strength Index (RSI) | 35.81 |
| Average Volume (20 Days) | 987,910 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AIM Vaccine had revenue of HKD 1.30 billion and -751.66 million in losses. Loss per share was -0.61.
| Revenue | 1.30B |
| Gross Profit | 845.96M |
| Operating Income | -231.32M |
| Pretax Income | -853.03M |
| Net Income | -751.66M |
| EBITDA | -85.44M |
| EBIT | -231.32M |
| Loss Per Share | -0.61 |
Balance Sheet
The company has 395.74 million in cash and 1.95 billion in debt, with a net cash position of -1.56 billion or -1.27 per share.
| Cash & Cash Equivalents | 395.74M |
| Total Debt | 1.95B |
| Net Cash | -1.56B |
| Net Cash Per Share | -1.27 |
| Equity (Book Value) | 3.27B |
| Book Value Per Share | 2.50 |
| Working Capital | -1.17B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 150.34M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 65.22%, with operating and profit margins of -17.83% and -57.95%.
| Gross Margin | 65.22% |
| Operating Margin | -17.83% |
| Pretax Margin | -65.76% |
| Profit Margin | -57.95% |
| EBITDA Margin | -6.59% |
| EBIT Margin | -17.83% |
| FCF Margin | n/a |
Dividends & Yields
AIM Vaccine does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.06% |
| Shareholder Yield | -1.06% |
| Earnings Yield | -21.28% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |